TOPLINE: According to a study of over five million patients with a neoplasm, those who received an immune checkpoint inhibitor (ICI) faced a 26% higher risk for rheumatoid arthritis (RA) than those receiving other types of cancer therapy. METHODOLOGY: Researchers conducted this retrospective observational study using data from the global federated research network TriNetX to …
Leave a Comment Leave a Comment
